Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial).
Santin M, Perez-Recio S, Grijota MD, Anibarro L, Barcala JM, De Souza-Galvao ML, Gijon P, Luque R, Sanchez F; RIFAKiD team trial. Santin M, et al. Among authors: anibarro l. PLoS One. 2022 Oct 21;17(10):e0276387. doi: 10.1371/journal.pone.0276387. eCollection 2022. PLoS One. 2022. PMID: 36269714 Free PMC article.
Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti-tumor necrosis factor-α therapy.
Casas S, Andreu A, Juanola X, Bordas X, Alcaide F, Moure R, Anibarro L, Cuchí E, Esteve M, Ortiz V, Guerra MR, Rodríguez J, Reina D, Salvador G, Guardiola J, Surís X, Pascual MA, Martí C, Martínez-Lacasa X, Cuquet J, Gonzalez L, Santin M. Casas S, et al. Among authors: anibarro l. Diagn Microbiol Infect Dis. 2011 Sep;71(1):57-65. doi: 10.1016/j.diagmicrobio.2010.12.020. Diagn Microbiol Infect Dis. 2011. PMID: 21851871
Executive summary of the guidelines for the use of interferon-γ release assays in the diagnosis of tuberculosis infection.
Santin M, García-García JM, Rigau D, Altet N, Anibarro L, Casas I, Díez N, García-Gasalla M, Martínez-Lacasa X, Penas A, Pérez-Escolano E, Sánchez F, Domínguez J; Panel of experts from the Mycobacteria Study Group (GEIM) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the Spanish Society of Respiratory Diseases and Thoracic Surgery (SEPAR). Santin M, et al. Among authors: anibarro l. Enferm Infecc Microbiol Clin. 2016 May;34(5):304-8. doi: 10.1016/j.eimc.2015.11.021. Epub 2016 Feb 28. Enferm Infecc Microbiol Clin. 2016. PMID: 26926262
Executive Summary of the Guidelines for the Use of interferon-gamma Release Assays in the Diagnosis of Tuberculosis Infection.
Santin M, García-García JM, Rigau D, Altet N, Anibarro L, Casas I, Díez N, García-Gasalla M, Martínez-Lacasa X, Penas A, Pérez-Escolano E, Sánchez F, Domínguez J; Grupo de expertos del Grupo de Estudio de Micobacterias (GEIM) de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC) y la Sociedad Española de Enfermedades Respiratorias y Cirugía torácica (SEPAR). Santin M, et al. Among authors: anibarro l. Arch Bronconeumol. 2016 Sep;52(9):477-81. doi: 10.1016/j.arbres.2016.02.020. Epub 2016 Jul 15. Arch Bronconeumol. 2016. PMID: 27424071 English, Spanish.
Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study.
Santin M, Morandeira-Rego F, Alcaide F, Rabuñal R, Anibarro L, Agüero-Balbín R, Casas-Garcia X, Pérez-Escolano E, Navarro MD, Sánchez F, Coira-Nieto A, Trigo-Daporta M, Martinez-Meñaca A, Gonzalez-Cuevas A, López-Prieto MD, Domínguez-Castellano A, Jové N; IL-2 Study Team. Santin M, et al. Among authors: anibarro l. Clin Microbiol Infect. 2016 Dec;22(12):1007.e1-1007.e5. doi: 10.1016/j.cmi.2016.09.004. Epub 2016 Sep 16. Clin Microbiol Infect. 2016. PMID: 27647563 Free article.
Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.
Ruhwald M, Aggerbeck H, Gallardo RV, Hoff ST, Villate JI, Borregaard B, Martinez JA, Kromann I, Penas A, Anibarro LL, de Souza-Galvão ML, Sánchez F, Rodrigo-Pendás JÁ, Noguera-Julian A, Martínez-Lacasa X, Tuñez MV, Fernández VL, Millet JP, Moreno A, Cobos N, Miró JM, Roldan L, Orcau A, Andersen P, Caylá JA; TESEC Working Group. Ruhwald M, et al. Among authors: anibarro ll. Lancet Respir Med. 2017 Apr;5(4):259-268. doi: 10.1016/S2213-2600(16)30436-2. Epub 2017 Feb 1. Lancet Respir Med. 2017. PMID: 28159608 Clinical Trial.
QuantiFERON-TB Gold In-Tube as a Confirmatory Test for Tuberculin Skin Test in Tuberculosis Contact Tracing: A Noninferiority Clinical Trial.
Muñoz L, Santin M, Alcaide F, Ruíz-Serrano MJ, Gijón P, Bermúdez E, Domínguez-Castellano A, Navarro MD, Ramírez E, Pérez-Escolano E, López-Prieto MD, Gutiérrez-Rodriguez J, Anibarro L, Calviño L, Trigo M, Cifuentes C, García-Gasalla M, Payeras A, Gasch O, Espasa M, Agüero R, Ferrer D, Casas X, González-Cuevas A, García-Zamalloa A, Bikuña E, Lecuona M, Galindo R, Ramírez-Lapausa M, Carrillo R; OPTIMIST Study Team. Muñoz L, et al. Among authors: anibarro l. Clin Infect Dis. 2018 Jan 18;66(3):396-403. doi: 10.1093/cid/cix745. Clin Infect Dis. 2018. PMID: 29020191 Free article. Clinical Trial.
Identification of Recent Tuberculosis Exposure Using QuantiFERON-TB Gold Plus, a Multicenter Study.
Pérez-Recio S, Pallarès N, Grijota-Camino MD, Sánchez-Montalvá A, Barcia L, Campos-Gutiérrez S, Pomar V, Rabuñal-Rey R, Balcells ME, Gazel D, Montiel N, Vicente D, Goić-Barišić I, Schön T, Paues J, Mareković I, Cacho-Calvo J, Barac A, Goletti D, García-Gasalla M, Barcala JM, Tórtola MT, Anibarro L, Suárez-Toste I, Moga E, Gude-Gonzalez MJ, Naves R, Karslıgil T, Martin-Peñaranda T, Stevanovic G, Trigo M, Rubio V, Karaoğlan İ, Bayram N, Alcaide F, Tebé C, Santin M; ESCMID Study Group for Mycobacterial Infections (ESGMYC) and the Mycobacteria Study Group (GEIM) of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC). Pérez-Recio S, et al. Among authors: anibarro l. Microbiol Spectr. 2021 Dec 22;9(3):e0097221. doi: 10.1128/Spectrum.00972-21. Epub 2021 Nov 10. Microbiol Spectr. 2021. PMID: 34756079 Free PMC article.
Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study.
Pérez-Recio S, Grijota-Camino MD, Anibarro L, Rabuñal-Rey R, Sabria J, Gijón-Vidaurreta P, Pomar V, García-Gasalla M, Domínguez-Castellano Á, Trigo M, Santos MJ, Cebollero A, Rodríguez S, Moga E, Penas-Truque A, Martos C, Ruiz-Serrano MJ, Garcia-de-Cara EI, Alcaide F, Santin M. Pérez-Recio S, et al. Among authors: anibarro l. PLoS One. 2023 Aug 30;18(8):e0285917. doi: 10.1371/journal.pone.0285917. eCollection 2023. PLoS One. 2023. PMID: 37647315 Free PMC article.
52 results